HOBOKEN, NJ—September 8, 2016—John Wiley and Sons, Inc., and The AlphaMed Company, Inc., dba AlphaMed Press today announced an expanded co-publishing partnership for AlphaMed’s prestigious portfolio of scholarly journals in stem cell research, regenerative and translational medicine, and oncology. With an outstanding track record of nearly thirty-five years as the founder and publisher of high-impact, peer-reviewed publications, The Oncologist, STEM CELLS, and STEM CELLS Translational Medicine, AlphaMed is a CEO Cancer Gold Standard accredited company globally recognized for its leading educational outreach programs, scientific meetings, and worldwide network of thought leaders.

Beginning in January 2017, Wiley will assume co-publishing responsibility for AlphaMed’s industry-leading publication,The Oncologist,along with its Open Access journal, STEM CELLS Translational Medicine.Wiley will continue to co-publish STEM CELLS, the primary publication for original research in stem and progenitor cell biology.This expanded partnership will enhance AlphaMed’s already significant reach and visibility, providing their authors and readers with innovative digital and technological capabilities by Wiley. 

“Wiley is proud to be selected as AlphaMed’s co-publishing partner,” said Andy Robinson, Senior Vice President and Managing Director, Society Services at Wiley.  “AlphaMed Press has long been the premier publisher in the stem cell and oncology fields and delivers a crucial forum for cutting edge research in these important disciplines. We look forward to working with AlphaMed colleagues to further our mutual mission to advance knowledge and education through the dissemination of high quality content and to help our partner meet its noble purpose to improve health outcomes.”

“AlphaMed welcomes with enthusiasm this broadened collaboration with Wiley as our co-publisher that is mutually dedicated to a common mission to attract and to speedily publish the best research that will providehopefor the catastrophically ill patient,” said Dr. Ann Murphy, President and Publisher of AlphaMed Press.  “It is in this context that we renew the pledge made by our Founding Editors of STEM CELLS 34 years ago to be ’Scientists in the Service of Science’.  Armed now with even greater scientific tools and insights, a renewal ofhopeis all the more proximate.  Together, we will collaboratively establish new global initiatives that will foster innovative research and clinical trials with evidence-based results that will translate into improved patient care.”

About AlphaMed Press

AlphaMed Press is a premier independent publisher with three internationally peer-reviewed journals dedicated to advancing knowledge and education in their focused disciplines: The Oncologist, STEM CELLS, and STEM CELLS Translational Medicine. Founded in 1983, we have offices in Durham, NC; San Francisco, CA; and Belfast, Northern Ireland. Visit the AlphaMed Press website at http://alphamedpress.com.

About Wiley

Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice and education. Through the Researchsegment, the Company provides digital and print scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising. The Professional Developmentsegment provides digital and print books, online assessment and training services, and test prep and certification. In Education, Wiley provides education solutions including online program management services for higher education institutions and course management tools for instructors and students, as well as print and digital content. The Company's website can be accessed at www.wiley.com.

Media Contacts:
Dawn Peters (US), Wiley

P: +1 781-388-8408, [email protected]
Follow us on Twitter @WileyNews

Sharon Lee, AlphaMed Press

P: +1 919-680-0011 F: 919-680-4411

[email protected]